Evidence map›Paper›PMID 30896765›Full record

ArticleJAMA ophthalmology2019

High-Resolution Adaptive Optics in Vivo Autofluorescence Imaging in Stargardt Disease.

Hongxin Song, Ethan A Rossi, Qiang Yang, Charles E Granger, Lisa R Latchney, Mina M Chung

Open access · bronzeAbstract read
In one paragraph

Article in JAMA ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Observational
  5. Multispectral label-freeJournal of biomedical optics · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Stargardt disease: Multimodal imaging: A review.Clinical & experimental ophthalmology · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Hongxin SongBeijing Tongren Eye Center, Beijing Institute Of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Ethan A RossiDepartment of Ophthalmology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Qiang YangCenter For Visual Science, University of Rochester, Rochester, New York.
Charles E GrangerCenter For Visual Science, University of Rochester, Rochester, New York.
Lisa R LatchneyFlaum Eye Institute, University of Rochester, Rochester, New York.
Mina M ChungCenter For Visual Science, University of Rochester, Rochester, New York.
University of Rochester · USCapital Medical University · CNUniversity of Pittsburgh · US

Funding

VISUAL SCIENCE RESEARCH CTR SUPPORTP30EY001319 · NEI · UNIVERSITY OF ROCHESTER · PI GREGORY C DEANGELIS · 1985 to 2026
$17.5M
Optics Instrumentation for Advanced Ophthalmic ImagingR01EY014375 · NEI · UNIVERSITY OF ROCHESTER · PI WILLIAMS, DAVID R · 2003 to 2012
$14.9M
RETINAL MECHANISMS AND VISUAL RESOLUTIONR01EY004367 · NEI · UNIVERSITY OF ROCHESTER · PI HUNTER, JENNIFER J, WILLIAMS, DAVID R · 1986 to 2020
$7.3M
Tracking change in rod, cone, and RPE mosaics independently in geographic atrophyF32EY021669 · NEI · UNIVERSITY OF ROCHESTER · PI ROSSI, ETHAN A · 2011 to 2011
$48k
NEI NIH HHS F32 EY021669NEI NIH HHS P30 EY001319NEI NIH HHS R01 EY004367NEI NIH HHS R01 EY014375
6 · The paper itself

Abstract

Importance: Targeting the early pathogenic steps in Stargardt disease type 1 (STGD1) is critical to advance our understanding of this condition and to develop potential therapies. Lipofuscin precursors may accumulate within photoreceptors, leading to photoreceptor damage and preceding retinal pigment epithelial (RPE) cell death. Fluorescence adaptive optics scanning light ophthalmoscopy can provide autofluorescence (AF) images in vivo with microscopic resolution to elucidate the cellular origin of AF abnormalities in STGD1. Objective: To study the spatial distribution of photoreceptor, RPE, and AF abnormalities in patients with STGD1 at a cellular level. Design, Setting, and Participants: Cross-sectional study using fluorescence adaptive optics scanning light ophthalmoscopy to compare the cones, rods, and RPE cells between 3 patients with STGD1 and 1 control individual. Imaging sessions were conducted at the University of Rochester. Further image analyses were performed at Beijing Tongren Eye Center and the University of Pittsburgh. Data were collected from August 2015 to February 2016, and analysis began in March 2016. Main Outcomes and Measures: Structural appearance of cones, rods, and AF structures at different retinal locations. Results: Two women and 1 man with macular atrophy phenotype of STGD1 and visual acuity loss ranging from 20/30 to 20/150 and 1 woman without STGD1 with 20/20 visual acuity were analyzed. Cone and rod spacing was increased in all 3 patients at all locations where photoreceptors were detectable; most cones had a dark appearance. Autofluorescence was low contrast but contained structures consistent with RPE cells in the periphery. In the transition zone peripheral to the foveal atrophic lesion, the structural pattern of AF was more consistent with photoreceptors than RPE cells. The microscopic AF was disrupted within areas of clinically detectable atrophy. Conclusions and Relevance: Adaptive optics high-resolution images of cones, rods, and RPE cells at the leading disease front of STGD1 macular atrophy show an AF pattern that appears to colocalize with photoreceptors or may result from a combination of AF signals from both RPE cells and photoreceptors. This in vivo observation is consistent with histologic reports of fluorescence arising from photoreceptors in STGD1. The detection of bisretinoid accumulation in the photoreceptors may represent an early pathologic step in STGD1 and can provide an in vivo imaging tool to act as a biomarker of disease progression.

Indexed as

AdultCross-Sectional StudiesFemaleFluorescein AngiographyFundus OculiHumansMaleOphthalmoscopyOptical ImagingOptics and PhotonicsPhotoreceptor Cells, VertebrateRetinal Pigment EpitheliumStargardt DiseaseYoung Adult

Identifiers

PMID30896765
PMCPMC6567847
OpenAlexW2923369968

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.